Improved growth of toddlers fed a milk containing synbiotics

Asia Pacific Journal of Clinical Nutrition

Volumn 20, Issue 1, 2011, Pages 69-76

  Firmansyah, Agus ^a   Dwipoerwantoro, Pramita G ^a   Kadim, Muzal ^a   Alatas, Safira ^a   Conus, Nelly ^b   Lestarina, Leilani ^b   Bouisset, Florilene ^b   Steenhout, Philippe ^b  

^a UNIVERSITY OF INDONESIA   (Indonesia)

^b NESTLÉ RESEARCH CENTER   (Switzerland)

Author keywords

Bifidobacterium; Fructo oligosaccharide; Growth; Lactobacillus; Long chain polyunsaturated fatty acids

Indexed keywords

BACTERIA (MICROORGANISMS); BIFIDOBACTERIUM; BIFIDOBACTERIUM LONGUM; ENTEROCOCCUS; LACTOBACILLUS;

IDOLAX; IMMUNOGLOBULIN G; INULIN; OLIGOSACCHARIDE; SYNBIOTIC AGENT; UNSATURATED FATTY ACID; VIRUS VACCINE;

ANIMAL; ARTICLE; BIFIDOBACTERIUM; BLOOD; BODY HEIGHT; BODY MASS; CHEMISTRY; CHILD DEVELOPMENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FECES; FEMALE; HUMAN; IMMUNOLOGY; INDONESIA; INFANT; LACTOBACILLUS RHAMNOSUS; MALE; MICROBIOLOGY; MILK; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; WEIGHT GAIN;

ANIMALS; BIFIDOBACTERIUM; BODY HEIGHT; BODY MASS INDEX; CHILD DEVELOPMENT; DOUBLE-BLIND METHOD; FATTY ACIDS, UNSATURATED; FECES; FEMALE; HUMANS; IMMUNOGLOBULIN G; INDONESIA; INFANT; INULIN; LACTOBACILLUS RHAMNOSUS; MALE; MILK; OLIGOSACCHARIDES; SYNBIOTICS; VIRAL VACCINES; WEIGHT GAIN;

EID: 79955672237     PISSN: 09647058     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Chouraqui JP, Van Egroo LD, Fichot MC. Acidified milk formula supplemented with bifidobacterium lactis: impact on infant diarrhea in residential care settings. J Pediatr Gastroenterol Nutr. 2004;38:288-92.
2. Marteau PR, de Vrese M, Cellier CJ, Schrezenmeir J. Protection from gastrointestinal diseases with the use of probiotics. Am J Clin Nutr. 2001;73:430S-36S.
3. Kullen MJ, Bettler J. The delivery of probiotics and prebiotics to infants. Curr Pharm Des. 2005;11:55-74.
4. Salminen SJ, Gueimonde M, Isolauri E. Probiotics that modify disease risk. J Nutr. 2005;135:1294-8.
5. Newburg DS. Innate immunity and human milk. J Nutr. 2005;135:1308-12.
6. Kukkonen K, Savilahti E, Haahtela T, Juntunen-Backman K, Korpela R, Poussa T, Tuure T, Kuitunen M. Probiotics and prebiotic galacto-oligosaccharides in the prevention of allergic diseases: a randomized, double-blind, placebocontrolled trial. J Allergy Clin Immunol. 2007;119:192-8.
7. Kalliomaki M, Salminen S, Poussa T, Arvilommi H, Isolauri E. Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial. Lancet. 2003;361:1869-71.
8. Kuitunen M, Kukkonen K, Juntunen-Backman K, Korpela R, Poussa T, Tuure T, Haahtela T, Savilahti E. Probiotics prevent IgE-associated allergy until age 5 years in cesareandelivered children but not in the total cohort. J Allergy Clin Immunol. 2009;123:335-41.
9. Collins MD, Gibson GR. Probiotics, prebiotics, and synbiotics: approaches for modulating the microbial ecology of the gut. Am J Clin Nutr. 1999;69:1052S-57S.
10. Calder PC, Krauss-Etschmann S, de Jong EC, Dupont C, Frick JS, Frokiaer H et al. Early nutrition and immunity -progress and perspectives. Br J Nutr. 2006;96:774-90.
11. Lewis SJ, Heaton KW. Stool form scale as a useful guide to intestinal transit time. Scand J Gastroenterol. 1997;32:920-4.
12. Langendijk PS, Schut F, Jansen GJ, Raangs GC, Kamphuis GR, Wilkinson MH, Welling, GW. Quantitative fluorescence in situ hybridization of Bifidobacterium spp. with genus-specific 16S rRNA-targeted probes and its application in fecal samples. Appl Environ Microbiol. 1995;61:3069-75.
13. Amann RI, Binder BJ, Olson RJ, Chisholm SW, Devereux R, Stahl DA. Combination of 16S rRNA-targeted oligonucleotide probes with flow cytometry for analyzing mixed microbial populations. Appl Environ Microbiol. 1990;56: 1919-25.
14. Bouwstra H, Dijck-Brouwer DA, Boehm G, Boersma ER, Muskiet FA, Hadders-Algra M. Long-chain polyunsaturated fatty acids and neurological developmental outcome at 18 months in healthy term infants. Acta Paediatr. 2005;94:26-32.
15. Vendt N, Grunberg H, Tuure T, Malminiemi O, Wuolijoki E, Tillmann V, Sepp E, Korpela R. Growth during the first 6 months of life in infants using formula enriched with Lactobacillus rhamnosus GG: double-blind, randomized trial. J Hum Nutr Diet. 2006;19:51-8.
16. Steenhout PG, Rochat F, Hager C. The Effect of Bifidobacterium lactis on the Growth of Infants: A Pooled Analysis of Randomized Controlled Studies. Ann Nutr Metab. 2009; 55:334-40.
17. Kukkonen K, Nieminen T, Poussa T, Savilahti E, Kuitunen M. Effect of probiotics on vaccine antibody responses in infancy--a randomized placebo-controlled double-blind trial. Pediatr Allergy Immunol. 2006;17:416-21.
18. Taylor AL, Hale J, Wiltschut J, Lehmann H, Dunstan JA, Prescott SL. Effects of probiotic supplementation for the first 6 months of life on allergen- and vaccine-specific immune responses. Clin Exp Allergy. 2006;36:1227-35.
19. Smithers LG, Gibson RA, McPhee A, Makrides M. Effect of long-chain polyunsaturated fatty acid supplementation of preterm infants on disease risk and neurodevelopment: a systematic review of randomized controlled trials. Am J Clin Nutr. 2008;87:912-20.
20. Simmer K, Patole SK, Rao SC. Longchain polyunsaturated fatty acid supplementation in infants born at term. Cochrane Database Syst Rev. 2008(1):CD000376.